We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002493:SZSERongsheng Petrochemical Co., Ltd. Analysis

Data as of 2026-03-15 - not real-time

CN¥13.62

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Rongsheng Petrochemical is trading at CNY 13.62, comfortably above its 50‑day SMA (13.43) but still below the 20‑day SMA (14.80), indicating a short‑term pull‑back within a broader bullish trend. Volume is rising and the 30‑day volatility is elevated at 56%, while the computed beta of 0.30 suggests limited market‑wide price swings. Fundamentally, the company faces serious pressure: revenue fell 5.7% YoY, profit margins are razor‑thin (0.24% net margin), and free cash flow is negative despite strong operating cash flow. The balance sheet is heavily leveraged with a debt‑to‑equity ratio of over 220 and a payout ratio of 125%, making the 0.73% dividend unlikely to be sustainable. Valuation metrics are mixed – a trailing PE of 170 is extreme, yet the DCF‑derived fair value of ~CNY 17.6 sits above the current price, hinting at modest upside if earnings improve. Overall, the stock sits at a technical support level (≈13.37) with bearish MACD momentum, while the fundamental backdrop is dominated by high leverage and weak profitability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support (13.37) with bearish MACD histogram
  • Increasing volume but high short‑term volatility
  • Weak recent earnings and negative free cash flow

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward EPS forecast implies a forward PE of ~29, a significant earnings improvement
  • DCF fair value above current price suggests modest upside
  • Increasing market participation and improving cash‑flow generation

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Extremely high debt‑to‑equity ratio (>220) and unsustainable dividend payout
  • Persistently low profit margins and modest ROE (~3%)
  • Potential regulatory and environmental headwinds in China’s chemicals sector

Key Metrics & Analysis

Financial Health

Revenue Growth-5.70%
Profit Margin0.24%
P/E Ratio170.3
ROE3.08%
ROA1.49%
Debt/Equity220.70
P/B Ratio3.0
Op. Cash FlowCN¥38.5B
Free Cash FlowCN¥-17444294656

Technical Analysis

TrendBullish
RSI44.3
SupportCN¥13.37
ResistanceCN¥16.38
MA 20CN¥14.80
MA 50CN¥13.43
MA 200CN¥10.38
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueCN¥17.60
Target PriceCN¥11.06
Upside/Downside-18.78%
GradeFair
TypeValue
Dividend Yield0.73%

Risk Assessment

Beta0.30
Volatility56.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.